Viridian Therapeutics (1S1.F) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.08
-0.98
-0.87
-0.77

Details

Expected EPS
-0.8522887108499999
Actual EPS
-0.7669484999999999
Surprise EPS
0.09
Surprise Percent
+10.01%

Description

⁨Viridian Therapeutics⁩ (⁦1S1.F⁩) has reported earnings of ⁦-0.7669484999999999⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts